|
|
1.
|
GLIBENTEK
| Application Number |
216158400 |
| Status |
Registered |
| Filing Date |
2022-01-21 |
| Registration Date |
2026-02-23 |
| Owner |
AMMTek (France)
|
| NICE Classes ? |
- 05 - Pharmaceutical, veterinary and sanitary products
- 10 - Medical apparatus and instruments
|
Goods & Services
(1) Drug delivery agents in the form of capsules, liquids, tablets, and oral transmucosals that facilitate the delivery of pharmaceutical and biological preparations; pharmaceutical and biological preparations for use in treatment of neonatal diabetes mellitus, a monogenic form of diabetes diagnosed in infancy; pharmaceutical and biological preparations for use in treatment of hyper glycemia in premature babies, namely, formulations for lowering blood glucose levels in neonates with insulin dysregulation; Medicines for human purposes, for treatment of neonatal diabetes; Medicines for human purposes, for treatment of hyper glycemia in premature babies
(2) Medical apparatus, devices, and instruments for treating neonatal diabetes; Medical apparatus, devices, and instruments for treating hyper glycemia in premature babies
|
2.
|
Liquid formulations of hypoglycaemic sulfonamides
| Application Number |
17412305 |
| Grant Number |
11911505 |
| Status |
In Force |
| Filing Date |
2021-08-26 |
| First Publication Date |
2021-12-09 |
| Grant Date |
2024-02-27 |
| Owner |
AMMTEK (France)
|
| Inventor |
Berdugo Polak, Marianne
|
Abstract
The present invention relates to a liquid pharmaceutical formulation of hypoglycaemic sulfonamide, intended for oral or ophthalmic administration. The present invention relates in particular to an oral formulation particularly suitable for paediatric use.
IPC Classes ?
- A61K 9/10 - DispersionsEmulsions
- A61K 47/38 - CelluloseDerivatives thereof
- A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A61K 9/00 - Medicinal preparations characterised by special physical form
|
3.
|
Liquid formulations of hypoglycaemic sulfonamides
| Application Number |
14380080 |
| Grant Number |
11110059 |
| Status |
In Force |
| Filing Date |
2013-02-28 |
| First Publication Date |
2015-02-19 |
| Grant Date |
2021-09-07 |
| Owner |
AMMTEK (France)
|
| Inventor |
Berdugo Polak, Marianne
|
Abstract
The present invention relates to a liquid pharmaceutical formulation of hypoglycaemic sulfonamide, intended for oral or ophthalmic administration. The present invention relates in particular to an oral formulation particularly suitable for paediatric use.
IPC Classes ?
- A61K 9/10 - DispersionsEmulsions
- A61K 47/38 - CelluloseDerivatives thereof
- A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A61K 9/00 - Medicinal preparations characterised by special physical form
|
4.
|
LIQUID FORMULATIONS OF HYPOGLYCAEMIC SULPHONAMIDES
| Document Number |
02863180 |
| Status |
In Force |
| Filing Date |
2013-02-28 |
| Open to Public Date |
2013-09-06 |
| Grant Date |
2020-03-24 |
| Owner |
AMMTEK (France)
|
| Inventor |
Berdugo Polak, Marianne
|
Abstract
The present invention relates to a liquid pharmaceutical formulation of hypoglycaemic sulphonamide, intended for oral or ophthalmic administration. The present invention relates, in particular, to an oral formulation particularly suited to paediatric use.
IPC Classes ?
- A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A61P 27/02 - Ophthalmic agents
|
5.
|
LIQUID FORMULATIONS OF HYPOGLYCAEMIC SULPHONAMIDES
| Application Number |
FR2013050421 |
| Publication Number |
2013/128131 |
| Status |
In Force |
| Filing Date |
2013-02-28 |
| Publication Date |
2013-09-06 |
| Owner |
AMMTEK (France)
|
| Inventor |
Berdugo Polak, Marianne
|
Abstract
The present invention relates to a liquid pharmaceutical formulation of hypoglycaemic sulphonamide, intended for oral or ophthalmic administration. The present invention relates, in particular, to an oral formulation particularly suited to paediatric use.
IPC Classes ?
- A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A61P 27/02 - Ophthalmic agents
|
|
